(Q36755124)

English

Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo

scientific article published on January 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

author name string

Quyyumi AA

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Wright C

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mockus L

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Shackell M

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sutton GC

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Fox KM

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 January 1985

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

British Heart Journal

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

53

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

47-52

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Regulation of coronary blood flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

29 September 2017

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: Labetalol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

29 September 2017

Coronary-Artery Spasm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

29 September 2017

Labetalol in long-term treatment of hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

29 September 2017

Effects of Alpha Adrenergic Blockade upon Coronary Hemodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

29 September 2017

Pharmacological effects of labetalol in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

29 September 2017

Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

28 June 2018

Alpha and beta adrenergic blockade in hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

28 June 2018

"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

28 June 2018

Dosage and the pharmacokinetics of cytotoxic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

28 June 2018

Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

5 September 2018

Beneficial effect of labetalol in hypertensive patients with angina pectoris.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

5 September 2018

Pharmacology of labetalol in experimental animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=481720

5 September 2018

Coronary spasm and acute myocardial infarction--new possibility for treatment and prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of coronary vasospasm in the pathogenesis of myocardial ischemia and angina pectoris

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monotherapy with labetalol in the treatment of mild hypertension: A double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/3881105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.53.1.47

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36755124&oldid=1516078117"